These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 15851230)

  • 1. Ciprofloxacin-induced acquired long QT syndrome.
    Prabhakar M; Krahn AD
    Heart Rhythm; 2004 Nov; 1(5):624-6. PubMed ID: 15851230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT Interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator.
    Kaźmierczak J; Peregud-Pogorzelska M; Rzeuski R
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):1043-6. PubMed ID: 17669094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin-induced torsade de pointes.
    Flanagan MC; Mitchell ES; Haigney MC
    Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs.
    Cubeddu LX
    Am J Ther; 2003; 10(6):452-7. PubMed ID: 14624285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug induced QT prolongation].
    Altmann D; Eggmann U; Ammann P
    Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of prolonged QT interval and torsades de pointes due to ciprofloxacin.
    Salinas Arce J; Romero R; Solorzano P
    Rev Esp Cardiol; 2010 Jan; 63(1):111-2. PubMed ID: 20089234
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes.
    Owens RC
    Pharmacotherapy; 2001 Mar; 21(3):301-19. PubMed ID: 11253855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine.
    Letsas KP; Sideris A; Kounas SP; Efremidis M; Korantzopoulos P; Kardaras F
    Int J Cardiol; 2006 May; 109(2):273-4. PubMed ID: 15935493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
    Nair MK; Patel K; Starer PJ
    Addiction; 2008 Dec; 103(12):2062-4. PubMed ID: 19469750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug.
    Badshah A; Janjua M; Younas F; Halabi AR; Cotant JF
    Am J Med Sci; 2009 Aug; 338(2):164-6. PubMed ID: 19680025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia.
    Nagele P; Pal S; Brown F; Blood J; Miller JP; Johnston J
    Anesthesiology; 2012 Aug; 117(2):321-8. PubMed ID: 22692379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
    Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
    Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin-induced torsade de pointes.
    Ibrahim M; Omar B
    Am J Emerg Med; 2012 Jan; 30(1):252.e5-9. PubMed ID: 21075583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
    Briasoulis A; Agarwal V; Pierce WJ
    Cardiology; 2011; 120(2):103-10. PubMed ID: 22156660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
    Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F
    Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QT interval prolongation and Torsades de Pointes in a patient receiving zolpidem and amiodarone.
    Letsas KP; Filippatos GS; Kounas SP; Efremidis M; Sideris A; Kardaras F
    Cardiology; 2006; 105(3):146-7. PubMed ID: 16449812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.